Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 2 Medications Archives
Print | Email | Share | Comments (10)

Byetta Dusts Insulin In Year-Long Trial


Dec 11, 2007

In a recent randomized study, 69 people with type 2 diabetes who were already taking metformin were given either Byetta or Lantus for a full year. When the results were in, Byetta came out ahead on several fronts.

Byetta controlled blood sugar about as well as Lantus; both medicines reduced A1c's by slightly less than a point. But when it came to hypoglycemia, Byetta took the honors: 24.2 percent of the Lantus patients had an low blood sugar episode during the trial, compared to only 8.3 percent of the Byetta group.

Where Byetta really shone was in weight loss. The Byetta patients lost about eight pounds, but the Lantus group gained about two pounds.

With regard to beta cell function, Byetta won out as well. The patients' beta cell health was assessed by measuring their secretion of C-peptide, a byproduct of the body's own insulin output. After the year of treatment, the Byetta group could produce considerably more C-peptide than the Lantus group was able to manage, indicating that the Byetta group's beta cells were in robust health compared to the beta cells of the Lantus group.

Usually patients are started on Byetta at five micrograms twice a day for at least thirty days, but then later upped to ten micrograms twice daily. In this study, the Byetta doses were increased to as much as twenty micrograms three times a day, a dosage that is not yet approved by the FDA.

Source: Lilly Press Release, September 2007


Categories: A1c Test, Blood Sugar, Byetta, Diabetes, Diabetes, Insulin, Lantus, Low Blood Sugar, Type 2 Issues, Type 2 Medications



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 10 comments - Dec 11, 2007

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.